Kymera Therapeutics, Inc.
KYMR · XNASCIK 1815442fmd_15Z6766MHY6T2ZR7KJDE8GNFWCManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 29 periods
Loading
Latest annual · FY2025
Millions- Free cash flow
- (234)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (147)
- Net income
- (132)
- Free cash flow
- (78)
Kymera Therapeutics, Inc. (KYMR) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $39.2 million | $47.1 million | -16.7% | 10-K 2026-02-26 · proof |
| Gross profit | $0 | $0 | 10-K 2026-02-26 · proof | |
| Operating income | -$349.4 million | -$261.6 million | 10-K 2026-02-26 · proof | |
| Net income | -$311.4 million | -$223.9 million | 10-K 2026-02-26 · proof | |
| Cash from operating activities | -$232.9 million | -$194.5 million | 10-K 2026-02-26 · proof | |
| Free cash flow | -$234.3 million | -$207.3 million | 10-K 2026-02-26 · proof | |
| Total assets | $1.7 billion | $978 million | +78.2% | 10-K 2026-02-26 · proof |
| Total liabilities | $163.1 million | $142.4 million | +14.6% | 10-K 2026-02-26 · proof |
| Cash and cash equivalents | $357 million | $120.3 million | +196.9% | 10-K 2026-02-26 · proof |
- What was Kymera Therapeutics, Inc. (KYMR)'s revenue in fiscal 2025?
- Kymera Therapeutics, Inc. (KYMR) reported revenue of $39.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $47.1 million the year before (-16.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Kymera Therapeutics, Inc. (KYMR)'s gross profit in fiscal 2025?
- Kymera Therapeutics, Inc. (KYMR) reported gross profit of $0 for fiscal 2025 (the year ended Dec 31, 2025), against $0 the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Kymera Therapeutics, Inc. (KYMR)'s operating income in fiscal 2025?
- Kymera Therapeutics, Inc. (KYMR) reported operating income of -$349.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$261.6 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Kymera Therapeutics, Inc. (KYMR)'s net income in fiscal 2025?
- Kymera Therapeutics, Inc. (KYMR) reported net income of -$311.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$223.9 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Kymera Therapeutics, Inc. (KYMR)'s cash from operating activities in fiscal 2025?
- Kymera Therapeutics, Inc. (KYMR) reported cash from operating activities of -$232.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$194.5 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What was Kymera Therapeutics, Inc. (KYMR)'s free cash flow in fiscal 2025?
- Kymera Therapeutics, Inc. (KYMR) reported free cash flow of -$234.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$207.3 million the year before. Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Kymera Therapeutics, Inc. (KYMR)'s total assets?
- As of Dec 31, 2025, Kymera Therapeutics, Inc. (KYMR) reported total assets of $1.7 billion, against $978 million a year earlier (+78.2%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Kymera Therapeutics, Inc. (KYMR)'s total liabilities?
- As of Dec 31, 2025, Kymera Therapeutics, Inc. (KYMR) reported total liabilities of $163.1 million, against $142.4 million a year earlier (+14.6%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
- What are Kymera Therapeutics, Inc. (KYMR)'s cash and cash equivalents?
- As of Dec 31, 2025, Kymera Therapeutics, Inc. (KYMR) reported cash and cash equivalents of $357 million, against $120.3 million a year earlier (+196.9%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:KYMR&period_type=annual&limit=5"Information only, not investment advice.